Christine Hoffer

1.3k total citations
26 papers, 1.0k citations indexed

About

Christine Hoffer is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmacology. According to data from OpenAlex, Christine Hoffer has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 12 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Christine Hoffer's work include Pharmacological Effects and Toxicity Studies (12 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Christine Hoffer is often cited by papers focused on Pharmacological Effects and Toxicity Studies (12 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Christine Hoffer collaborates with scholars based in United States, Norway and Germany. Christine Hoffer's co-authors include Evan D. Kharasch, Dale Whittington, Alysa Walker, Pamela Sheffels, E D Kharasch, Nina Isoherranen, Kenneth E. Thummel, Ola Dale, Kent L. Kunze and Ian E. Templeton and has published in prestigious journals such as Anesthesiology, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Christine Hoffer

24 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Hoffer United States	18	452	429	319	229	149	26	1.0k
Séverine Crettol Switzerland	18	586 1.3×	454 1.1×	286 0.9×	271 1.2×	193 1.3×	40	1.5k
Johanna Sistonen Finland	18	728 1.6×	300 0.7×	345 1.1×	109 0.5×	98 0.7×	34	1.3k
Christoph Wandel United States	16	590 1.3×	531 1.2×	734 2.3×	125 0.5×	124 0.8×	41	1.6k
Martine Monnat Switzerland	11	230 0.5×	176 0.4×	107 0.3×	181 0.8×	151 1.0×	23	697
Srikanth C. Nallani United States	11	279 0.6×	241 0.6×	189 0.6×	80 0.3×	302 2.0×	17	877
Pyry A. J. Välitalo Netherlands	18	161 0.4×	355 0.8×	130 0.4×	176 0.8×	85 0.6×	33	860
Kelly L. Cozza United States	17	368 0.8×	236 0.6×	95 0.3×	148 0.6×	88 0.6×	52	1.2k
Harri Luurila Finland	12	399 0.9×	236 0.6×	277 0.9×	100 0.4×	42 0.3×	20	897
Dolores Ochoa Spain	25	548 1.2×	273 0.6×	251 0.8×	67 0.3×	99 0.7×	98	1.6k
Jacqueline B. McCrea United States	26	311 0.7×	188 0.4×	279 0.9×	111 0.5×	54 0.4×	77	2.0k

Countries citing papers authored by Christine Hoffer

Since Specialization

Citations

This map shows the geographic impact of Christine Hoffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Hoffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Hoffer more than expected).

Fields of papers citing papers by Christine Hoffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Hoffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Hoffer. The network helps show where Christine Hoffer may publish in the future.

Co-authorship network of co-authors of Christine Hoffer

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Hoffer. A scholar is included among the top collaborators of Christine Hoffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Hoffer. Christine Hoffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fais, Rafael Sobrano, Matthew D. Rosenbaum, Avram Walts, et al.. (2024). NLRP3-induced Contractile Dysfunction in Right Ventricle Cardiomyocytes Is Sexually Dimorphic and Modified by 17β-estradiol Via Estrogen Receptor α. A4695–A4695.

Hoffer, Christine, et al.. (2024). Rhabdomyolysis of Infectious Etiology with Creatine Kinase Above One Million: A Case Report. American Journal of Case Reports. 26. e946364–e946364.

Sharar, Sam R., et al.. (2016). Circumplex Model of Affect: A Measure of Pleasure and Arousal During Virtual Reality Distraction Analgesia. Games for Health Journal. 5(3). 197–202. 69 indexed citations

Kharasch, Evan D., et al.. (2012). Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics. Clinical Pharmacology & Therapeutics. 91(4). 673–684. 55 indexed citations

Kharasch, Evan D., et al.. (2012). Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A). Anesthesiology. 116(2). 432–447. 30 indexed citations

Le, Dac‐Nhuong, S R Sharar, Hunter G. Hoffman, et al.. (2011). A pilot study demonstrating effective virtual reality analgesia in the elderly. Journal of Pain. 12(4). P79–P79. 3 indexed citations

Kharasch, Evan D., et al.. (2009). Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity. Drug and Alcohol Dependence. 101(3). 158–168. 56 indexed citations

Kharasch, E D, et al.. (2008). Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: I. Evidence Against CYP3A Mediation of Methadone Clearance. Clinical Pharmacology & Therapeutics. 84(4). 497–505. 65 indexed citations

Kharasch, E D, et al.. (2008). Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: II. Ritonavir Effects on CYP3A and P-Glycoprotein Activities. Clinical Pharmacology & Therapeutics. 84(4). 506–512. 76 indexed citations

10.

Templeton, Ian E., Kenneth E. Thummel, E D Kharasch, et al.. (2007). Contribution of Itraconazole Metabolites to Inhibition of CYP3A4 In Vivo. Clinical Pharmacology & Therapeutics. 83(1). 77–85. 103 indexed citations

11.

Kharasch, Evan D., Alysa Walker, Nina Isoherranen, et al.. (2007). Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam. Clinical Pharmacology & Therapeutics. 82(4). 410–426. 77 indexed citations

12.

Kirby, Brian, et al.. (2006). Simultaneous Measurement of In Vivo P‐glycoprotein and Cytochrome P450 3A Activities. The Journal of Clinical Pharmacology. 46(11). 1313–1319. 38 indexed citations

13.

Kharasch, Evan D., Dale Whittington, Christine Hoffer, et al.. (2005). Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo-??-Acetylmethadol. Clinical Pharmacokinetics. 44(7). 731–751. 9 indexed citations

14.

Kharasch, Evan D., Alysa Walker, Christine Hoffer, & Pamela Sheffels. (2005). Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimally Invasive and Noninvasive Probes for Hepatic and First‐Pass CYP3A Activity. The Journal of Clinical Pharmacology. 45(10). 1187–1197. 26 indexed citations

15.

Kharasch, Evan D., Christine Hoffer, & Dale Whittington. (2004). The effect of quinidine, used as a probe for the involvement of P‐glycoprotein, on the intestinal absorption and pharmacodynamics of methadone. British Journal of Clinical Pharmacology. 57(5). 600–610. 80 indexed citations

16.

Kharasch, Evan D., et al.. (2004). Quinidine as a Probe for the Role of P‐Glycoprotein in the Intestinal Absorption and Clinical Effects of Fentanyl. The Journal of Clinical Pharmacology. 44(3). 224–233. 60 indexed citations

17.

Kharasch, Evan D., Dale Whittington, & Christine Hoffer. (2004). Influence of Hepatic and Intestinal Cytochrome P4503A Activity on the Acute Disposition and Effects of Oral Transmucosal Fentanyl Citrate. Anesthesiology. 101(3). 729–737. 45 indexed citations

18.

Kharasch, Evan D., Christine Hoffer, & Dale Whittington. (2004). Influence of Age on the Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Fentanyl Citrate. Anesthesiology. 101(3). 738–743. 37 indexed citations

19.

Kharasch, Evan D., Christine Hoffer, Alysa Walker, & Pamela Sheffels. (2003). Disposition and miotic effects of oral alfentanil: A potential noninvasive probe for first‐pass cytochrome P4503A activity. Clinical Pharmacology & Therapeutics. 73(3). 199–208. 26 indexed citations

20.

Whittington, Dale, Pamela Sheffels, Christine Hoffer, & Evan D. Kharasch. (2003). Role of CYP3A in the metabolism, disposition and clinical effects of methadone in humans. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact